1-8 of 8
Ralph Weissleder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response

Huiyu Hu, Thomas S.C. Ng, Mikyung Kang, Ella Scott, Ran Li, Jeremy M. Quintana, Dylan Matvey, Venkata R. Vantaku, Ralph Weissleder, Sareh Parangi, Miles A. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3457–3470.
https://doi.org/10.1158/1078-0432.CCR-22-2976
Published: 01 September 2023
View article titled, Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Open the PDF for Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response in another window
Includes: Supplementary data
Journal Articles

Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle Sampling

Juhyun Oh, Jonathan C.T. Carlson, Christian Landeros, Hakho Lee, Scott Ferguson, William C. Faquin, John R. Clark, Mikael J. Pittet, Sara I. Pai, Ralph Weissleder
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4781–4793.
https://doi.org/10.1158/1078-0432.CCR-21-1252
Published: 01 September 2021
View article titled, Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle Sampling
Open the PDF for Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle Sampling in another window
Includes: Supplementary data
Journal Articles

Abstract B35: The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts

Lee A. Albacker, Rainer Kohler, Ralph Weissleder, Peter K. Sorger
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): B35.
https://doi.org/10.1158/1557-3265.PMS14-B35
Published: 13 February 2015
View article titled, Abstract B35: The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts
Journal Articles

Abstract PR07: The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts

Lee A. Albacker, Rainer Kohler, Ralph Weissleder, Peter K. Sorger
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): PR07.
https://doi.org/10.1158/1557-3265.PMS14-PR07
Published: 13 February 2015
View article titled, Abstract PR07: The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts
Journal Articles

Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer

Brinda Alagesan, Gianmarco Contino, Alexander R. Guimaraes, Ryan B. Corcoran, Vikram Deshpande, Gregory R. Wojtkiewicz, Aram F. Hezel, Kwok-Kin Wong, Massimo Loda, Ralph Weissleder, Cyril Benes, Jeffrey A. Engelman, Nabeel Bardeesy
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 396–404.
https://doi.org/10.1158/1078-0432.CCR-14-1591
Published: 14 January 2015
View article titled, Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer
Open the PDF for Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging

Anne Kleijn, John W. Chen, Jason S. Buhrman, Gregory R. Wojtkiewicz, Yoshiko Iwamoto, Martine L. Lamfers, Anat O. Stemmer-Rachamimov, Samuel D. Rabkin, Ralph Weissleder, Robert L. Martuza, Giulia Fulci
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4484–4493.
https://doi.org/10.1158/1078-0432.CCR-11-0575
Published: 05 July 2011
View article titled, Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging
Open the PDF for Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging in another window
Includes: Supplementary data
Journal Articles

Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin

Geoffrey D. Girnun, Liang Chen, Jessica Silvaggi, Ronny Drapkin, Lucian R. Chirieac, Robert F. Padera, Rabi Upadhyay, Scott B. Vafai, Ralph Weissleder, Umar Mahmood, Elnaz Naseri, Stephanie Buckley, Danan Li, Jeremy Force, Kate McNamara, George Demetri, Bruce M. Spiegelman, Kwok-Kin Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6478–6486.
https://doi.org/10.1158/1078-0432.CCR-08-1128
Published: 16 October 2008
View article titled, Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin
Open the PDF for Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin in another window
Journal Articles

The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

Gary J. Kelloff, Kenneth A. Krohn, Steven M. Larson, Ralph Weissleder, David A. Mankoff, John M. Hoffman, Jeanne M. Link, Kathryn Z. Guyton, William C. Eckelman, Howard I. Scher, Joyce O'Shaughnessy, Bruce D. Cheson, Caroline C. Sigman, James L. Tatum, George Q. Mills, Daniel C. Sullivan, Janet Woodcock
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (22): 7967–7985.
https://doi.org/10.1158/1078-0432.CCR-05-1302
Published: 18 November 2005
View article titled, The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
Open the PDF for The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development in another window